Under the 2006 and 2015 Plans, the total intrinsic value of options exercised during the nine months ended September 30, 2018 and 2017, was $5.2 million, and $11.7 million, respectively. The total intrinsic value of options surrendered during the nine months ended September 30, 2017, was $1.0 million.
At September 30, 2018, under the 2006 Plan, the outstanding stock options’ exercise price for 432,227 options is $3.83 per share, all of which are exercisable. The weighted average of the remaining lives of the outstanding stock options with an exercise price of $3.83 is approximately 4.62 years. The Company estimates the expected life of these stock options is ten years from the date of grant. For the $3.83 per share options, the weighted average fair value of options was determined using the Black-Scholes model assuming a ten-year life from grant date, a current share price and exercise price of $3.83, a risk-free interest rate of 3.57%, volatility of 40%, and no assumed dividend yield. Based on these assumptions, the fair value of these options is approximately $2.17 per share option granted.
At September 30, 2018, under the 2015 Plan, the risk-free interest rate is based on the U.S. Treasury rate for the expected life at the time of grant. The expected volatility is based on the average long-term historical volatilities of peer companies. We intend to continue to consistently use the same group of publicly traded peer companies to determine expected volatility until sufficient information regarding volatility of our share price becomes available or until the selected companies are no longer suitable for this purpose. Due to our limited trading history, we are using the simplified method presented by SEC Staff Accounting Bulletin No. 107 to calculate expected holding periods, which represent the periods of time for which options granted are expected to be outstanding. We will continue to use this method until we have sufficient historical exercise experience to give us confidence in the reliability of our calculations. The fair values of these options were determined using the Black-Scholes option pricing model.
The following table outlines the assumptions based on the number of options granted under the 2015 Plan.
| | February 10, 2017 | | | May 17, 2017 | | | March 7, 2018 | | | March 13, 2018 | |
Number of options granted | | | 40,000 | | | | 93,819 | | | | 98,100 | | | | 26,000 | |
Options outstanding at September 30, 2018 | | | 38,300 | | | | 84,665 | | | | 96,400 | | | | 26,000 | |
Number exercisable at September 30, 2018 | | | 11,900 | | | | 28,572 | | | | - | | | | 8,840 | |
Exercise price | | $ | 13.00 | | | $ | 15.41 | | | $ | 21.21 | | | $ | 21.49 | |
Remaining lives | | | 8.37 | | | | 8.63 | | | | 9.44 | | | | 9.46 | |
Risk free interest rate | | | 1.89 | % | | | 1.76 | % | | | 2.65 | % | | | 2.62 | % |
Expected volatility | | | 27.44 | % | | | 26.92 | % | | | 28.76 | % | | | 28.76 | % |
Expected life | | | 6.000 | | | | 6.000 | | | | 6.000 | | | | 5.495 | |
Dividend yield | | | - | | | | - | | | | 0.83 | % | | | 0.82 | % |
Fair value at grant date | | $ | 3.98 | | | $ | 4.60 | | | $ | 6.37 | | | $ | 6.18 | |
The Company has recorded compensation expense related to the options based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the options on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the options of approximately $0.2 million and $0.1 million for the three months ended September 30, 2018 and 2017. The Company recorded compensation expense related to the options of approximately $0.6 million and $0.2 million for the nine months ended September 30, 2018 and 2017. Total unrecognized compensation expense related to options at September 30, 2018, is $0.5 million, which will be expensed over 1.93 years.
Performance-Based Restricted Stock Units (“PRSUs”)
PRSUs are restricted stock units subject to both performance-based and service-based vesting conditions. The number of common stock shares a recipient will receive upon vesting of a PRSU will be calculated by reference to certain performance metrics related to the Company’s performance over a five-year period. PRSUs will vest on the measurement date, which is no more than 65 days after the performance period (provided the applicable service and performance conditions are satisfied). On March 31, 2017, the Company’s Board of Directors granted 94,000 PRSUs to employees of the Company. On March 7, 2018, the Company’s Board of Directors granted an additional 96,000 PRSUs to employees of the Company. The fair values of the PRSUs granted on March 31, 2017, and March 7, 2018, are $15.60 and $21.21, respectively, the Company’s stock price on the date of grant. As of September 30, 2018, there are 184,000 PRSUs outstanding, all of which are unvested. The Company recorded compensation expense related to the PRSUs of approximately $0.2 million and $0.1 million in the consolidated statements of income for the three months ended September 30, 2018 and 2017, based on the probability of achieving the performance condition. The Company recorded compensation expense related to the PRSUs of approximately $0.4 million and $0.2 million in the consolidated statements of income for the nine months ended September 30, 2018 and 2017. Total unrecognized compensation expense related to these awards at September 30, 2018, is $2.7 million which will be expensed over the service periods based on the probability of achieving the performance condition.
Note 14. Contingencies
Other major tobacco companies are defendants in product liability claims. In a number of these cases, the amounts of punitive and compensatory damages sought are significant and could have a material adverse effect on our business and results of operations. The Company is a defendant in certain cases which have been dormant for many years, which cases have now been dismissed with prejudice.
The Company is subject to several lawsuits alleging personal injuries resulting from malfunctioning vaporizer devices and may be subject to claims in the future relating to other NewGen products. The Company is still evaluating these claims and the potential defenses to them. For example, the Company did not design or manufacture the products at issue; rather, the Company was merely the distributor. Nonetheless, there can be no assurance that the Company will prevail in these cases, and they could have a material adverse effect on the financial position, results of operations, or cash flows of the Company.
Note 15. Income Per Share
The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations of net income:
| | Three Months Ended September 30, | |
| | 2018 | | | 2017 | |
| | Income | | | Shares | | | Per Share | | | Income | | | Shares | | | Per Share | |
Consolidated net income | | $ | 7,954 | | | | | | | | | $ | 7,374 | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Basic EPS: | | | | | | | | | | | | | | | | | | | | |
Weighted average | | | | | | | 19,378,054 | | | $ | 0.41 | | | | | | | | 19,085,329 | | | $ | 0.39 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Diluted EPS: | | | | | | | | | | | | | | | | | | | | | | | | |
Effect of dilutive securities: | | | | | | | | | | | | | | | | | | | | | | | | |
Stock options | | | | | | | 504,940 | | | | | | | | | | | | 504,095 | | | | | |
| | | | | | | 19,882,994 | | | $ | 0.40 | | | | | | | | 19,589,424 | | | $ | 0.38 | |
| | Nine Months Ended September 30, | |
| | 2018 | | | 2017 | |
| | Income | | | Shares | | | Per Share | | | Income | | | Shares | | | Per Share | |
Net income attributable to Turning Point Brands, Inc. | | $ | 20,305 | | | | | | | | | $ | 16,690 | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Basic EPS: | | | | | | | | | | | | | | | | | | | | |
Weighted average | | | | | | | 19,290,096 | | | $ | 1.05 | | | | | | | | 18,915,606 | | | $ | 0.88 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Diluted EPS: | | | | | | | | | | | | | | | | | | | | | | | | |
Effect of dilutive securities: | | | | | | | | | | | | | | | | | | | | | | | | |
Stock options | | | | | | | 477,571 | | | | | | | | | | | | 587,524 | | | | | |
| | | | | | | 19,767,667 | | | $ | 1.03 | | | | | | | | 19,503,130 | | | $ | 0.86 | |
Note 16. Segment Information
In accordance with ASC 280, Segment Reporting, the Company has three reportable segments: Smokeless products, Smoking products, and NewGen products. The Smokeless products segment (i) manufactures and markets moist snuff and (ii) contracts for and markets chewing tobacco products. The Smoking products segment (i) markets and distributes cigarette papers, tubes, and related products; (ii) markets and distributes finished cigars and MYO cigar wraps; and (iii) processes, packages, markets, and distributes traditional pipe tobaccos. The NewGen products segment (i) markets and distributes e-cigarettes, e-liquids, vaporizers, and certain other products without tobacco and/or nicotine; (ii) distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast, Vapor Shark, Vapor Supply, and IVG; and (iii) distributes a wide assortment of vaping related products to individual consumers via Vapor Shark, Vapor World, and VaporFi branded retail outlets in addition to online platforms. Smokeless and Smoking products are distributed primarily through wholesale distributors in the United States while NewGen products are distributed primarily through e-commerce to non-traditional retail outlets in the United States. The Other segment includes the costs and assets of the Company not assigned to one of the three reportable segments such as intercompany transfers, deferred taxes, deferred financing fees, and investments in subsidiaries.
The accounting policies of these segments are the same as those of the Company. Segment data includes a charge allocating corporate costs to the three reportable segments based on their respective net sales. Prior period corporate costs have been allocated in accordance with the current period allocation methodology to conform prior period segment operating income figures to current period presentation. The Company evaluates the performance of its segments and allocates resources to them based on gross profit.
The tables below present financial information about reported segments:
| | Three Months Ended | |
| | September 30, | |
| | 2018 | | | 2017 | |
| | | | | | |
Net sales | | | | | | |
Smokeless products | | $ | 21,743 | | | $ | 21,294 | |
Smoking products | | | 28,079 | | | | 26,860 | |
NewGen products | | | 33,527 | | | | 25,186 | |
| | $ | 83,349 | | | $ | 73,340 | |
| | | | | | | | |
Gross profit | | | | | | | | |
Smokeless products | | $ | 11,020 | | | $ | 11,516 | |
Smoking products | | | 14,814 | | | | 14,201 | |
NewGen products | | | 10,377 | | | | 7,251 | |
| | $ | 36,211 | | | $ | 32,968 | |
| | | | | | | | |
Operating income (loss) | | | | | | | | |
Smokeless products (1) | | $ | 4,114 | | | $ | 6,036 | |
Smoking products (2) | | | 8,595 | | | | 8,958 | |
NewGen products (3) | | | 371 | | | | (535 | ) |
Other (4) | | | (122 | ) | | | (25 | ) |
| | $ | 12,958 | | | $ | 14,434 | |
| | | | | | | | |
Interest expense | | | 3,836 | | | | 4,027 | |
Interest income | | | (134 | ) | | | (4 | ) |
Investment income | | | (89 | ) | | | (131 | ) |
Net periodic benefit (income) expense, excluding service cost | | | (45 | ) | | | 58 | |
| | | | | | | | |
Income before income taxes | | $ | 9,390 | | | $ | 10,484 | |
| | | | | | | | |
Capital expenditures | | | | | | | | |
Smokeless products | | $ | 251 | | | $ | 446 | |
Smoking products | | | - | | | | - | |
NewGen products | | | 274 | | | | 39 | |
| | $ | 525 | | | $ | 485 | |
| | | | | | | | |
Depreciation and amortization | | | | | | | | |
Smokeless products | | $ | 342 | | | $ | 341 | |
Smoking products | | | - | | | | - | |
NewGen products | | | 343 | | | | 255 | |
| | $ | 685 | | | $ | 596 | |
| | | | | | | | |
(1) Includes allocated corporate charges of $1,748 and $1,734 for the three months ended September 30, 2018 and 2017, respectively. | |
(2) Includes allocated corporate charges of $2,266 and $2,187 for the three months ended September 30, 2018 and 2017, respectively. | |
(3) Includes allocated corporate charges of $2,168 and $2,061 for the three months ended September 30, 2018 and 2017, respectively. | |
(4) “Other” includes the costs that are not assigned to the three reportable segments. | |
| | Nine Months Ended | |
| | September 30, | |
| | 2018 | | | 2017 | |
| | | | | | |
Net sales | | | | | | |
Smokeless products | | $ | 66,900 | | | $ | 63,563 | |
Smoking products | | | 84,403 | | | | 81,056 | |
NewGen products | | | 87,089 | | | | 67,595 | |
| | $ | 238,392 | | | $ | 212,214 | |
| | | | | | | | |
Gross profit | | | | | | | | |
Smokeless products | | $ | 34,546 | | | $ | 32,385 | |
Smoking products | | | 43,158 | | | | 42,018 | |
NewGen products | | | 26,111 | | | | 18,303 | |
| | $ | 103,815 | | | $ | 92,706 | |
| | | | | | | | |
Operating income (loss) | | | | | | | | |
Smokeless products (1) | | $ | 15,040 | | | $ | 15,256 | |
Smoking products (2) | | | 24,270 | | | | 25,663 | |
NewGen products (3) | | | (1,437 | ) | | | (1,916 | ) |
Other (4) | | | (372 | ) | | | (61 | ) |
| | $ | 37,501 | | | $ | 38,942 | |
| | | | | | | | |
Interest expense | | | 11,073 | | | | 13,010 | |
Interest income | | | (262 | ) | | | (8 | ) |
Investment income | | | (328 | ) | | | (334 | ) |
Loss on extinguishment of debt | | | 2,384 | | | | 6,116 | |
Net periodic benefit expense, excluding service cost | | | 176 | | | | 174 | |
| | | | | | | | |
Income before income taxes | | $ | 24,458 | | | $ | 19,984 | |
| | | | | | | | |
Capital expenditures | | | | | | | | |
Smokeless products | | $ | 1,140 | | | $ | 973 | |
Smoking products | | | - | | | | - | |
NewGen products | | | 388 | | | | 79 | |
| | $ | 1,528 | | | $ | 1,052 | |
| | | | | | | | |
Depreciation and amortization | | | | | | | | |
Smokeless products | | $ | 1,014 | | | $ | 1,046 | |
Smoking products | | | - | | | | - | |
NewGen products | | | 1,139 | | | | 672 | |
| | $ | 2,153 | | | $ | 1,718 | |
| | | | | | | | |
| | | | | | | | |
(1) Includes allocated corporate charges of $6,010 and $5,324 for the nine months ended September 30, 2018 and 2017, respectively. | |
(2) Includes allocated corporate charges of $7,585 and $6,789 for the nine months ended September 30, 2018 and 2017, respectively. | |
(3) Includes allocated corporate charges of $6,948 and $5,662 for the nine months ended September 30, 2018 and 2017, respectively. | |
(4) “Other” includes the costs that are not assigned to the three reportable segments. | |
| | September 30, 2018 | | | December 31, 2017 | |
Assets | | | | | | |
Smokeless products | | $ | 100,199 | | | $ | 94,559 | |
Smoking products | | | 141,129 | | | | 141,869 | |
NewGen products | | | 94,020 | | | | 44,914 | |
Other (1) | | | 983 | | | | 935 | |
| | $ | 336,331 | | | $ | 282,277 | |
(1) “Other” includes the assets that are not assigned to the three reportable segments. All goodwill has been allocated to the reportable segments. |
Revenue Disaggregation—Sales Channel
Revenues of the Smokeless and Smoking segments are primarily comprised of sales made to wholesalers while NewGen sales are made to wholesalers, retailers, and ultimate end-customers. NewGen net sales are broken out by sales channel below.
| | NewGen Segment | |
| | Three Months Ended | |
| | September 30, | |
| | 2018 | | | 2017 | |
| | | | | | |
Wholesalers | | $ | 1,892 | | | $ | 2,818 | |
Retail outlets | | | 22,473 | | | | 19,889 | |
End-customers | | | 9,162 | | | | 2,479 | |
| | $ | 33,527 | | | $ | 25,186 | |
| | NewGen Segment | |
| | Nine Months Ended | |
| | September 30, | |
| | 2018 | | | 2017 | |
| | | | | | |
Wholesalers | | $ | 6,572 | | | $ | 7,971 | |
Retail outlets | | | 63,185 | | | | 53,665 | |
End-customers | | | 17,332 | | | | 5,959 | |
| | $ | 87,089 | | | $ | 67,595 | |
Net Sales—Domestic vs. Foreign
The following table shows a breakdown of consolidated net sales between domestic and foreign customers.
| | Three Months Ended September 30, | |
| | 2018 | | | 2017 | |
Domestic | | $ | 78,529 | | | $ | 69,484 | |
Foreign | | | 4,820 | | | | 3,856 | |
Total | | $ | 83,349 | | | $ | 73,340 | |
| | Nine Months Ended September 30, | |
| | 2018 | | | 2017 | |
Domestic | | $ | 226,826 | | | $ | 203,210 | |
Foreign | | | 11,566 | | | | 9,004 | |
Total | | $ | 238,392 | | | $ | 212,214 | |
Note 17. Dividends
On November 9, 2017, the Company’s Board of Directors approved the initiation of a cash dividend to shareholders. The initial quarterly dividend of $0.04 per common share was paid on December 15, 2017, to shareholders of record at the close of business on November 27, 2017. The most recent dividend of $0.04 per common share was paid on October 12, 2018, to shareholders of record at the close of business on September 24, 2018.
Dividends are classified as restricted payments within the 2018 Credit Facility. The Company is generally permitted to make restricted payments provided that, at the time of payment, or as a result of payment, the Company is not in default on its debt covenants. Additional restrictions limit the aggregate amount of restricted, quarterly dividends during a fiscal year to the aggregate amount of mandatory and voluntary principal payments made on the priority term loans during the fiscal year.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion of the historical financial condition and results of operations in conjunction with our historical condensed consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements subject to risks and uncertainties that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”
The following discussion relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this Quarterly Report on Form 10-Q. In this discussion, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. We were incorporated in 2004 under the name North Atlantic Holding Company, Inc. On November 4, 2015, we changed our name to Turning Point Brands, Inc. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.
Organizational Structure
We, Turning Point Brands, Inc., are a holding company which owns North Atlantic Trading Company, Inc. (“NATC”), and its subsidiaries National Tobacco Company, L.P. (“NTC”), National Tobacco Finance, LLC (“NTFLLC”), North Atlantic Operating Company, Inc. (“NAOC”), North Atlantic Cigarette Company, Inc. (“NACC”), and RBJ Sales, Inc. (“RBJ”), and Turning Point Brands, LLC (“TPLLC”), and its subsidiaries Intrepid Brands, LLC (“Intrepid”), Vapor Beast, LLC (“VaporBeast”, f/k/a Smoke Free Technologies, Inc.), Vapor Shark, LLC, and its subsidiaries (collectively, “Vapor Shark”, f/k/a The Hand Media), Vapor Acquisitions Company, LLC (“Vapor Supply”), Vapor Finance, LLC (“VFIN”), and International Vapor Group, LLC and its subsidiaries (collectively, “IVG”).
Overview
We are a leading independent provider of Other Tobacco Products (“OTP”) in the U.S. We sell a wide range of products across the OTP spectrum including moist snuff tobacco (“MST”), loose leaf chewing tobacco, premium cigarette papers, make-your-own (“MYO”) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products; however, we do not sell cigarettes. We estimate the OTP industry generated approximately $11 billion in manufacturer revenue in 2017. In contrast to manufactured cigarettes, which have been experiencing declining volumes for decades based on data published by the Alcohol and Tobacco Tax and Trade Bureau (“TTB”), the OTP industry is demonstrating increased consumer appeal with low- to mid-single digit consumer unit growth as reported by Management Science Associates, Inc. (“MSAi”), a third-party analytics and informatics company. Under the leadership of a senior management team with an average of 22 years of experience in the tobacco industry, we have grown and diversified our business through new product launches, category expansions, and acquisitions while concurrently improving operational efficiency.
Products
We operate in three segments: Smokeless products, Smoking products and NewGen products. In our Smokeless products segment we (i) manufacture and market moist snuff and (ii) contract for and market loose leaf chewing tobacco products. In our Smoking products segment, we (i) market and distribute cigarette papers, tubes, and related products; (ii) market and distribute finished cigars and MYO cigar wraps; and (iii) process, package, market, and distribute traditional pipe tobaccos. In our NewGen products segment, we (i) market and distribute e-cigarettes, e-liquids, vaporizers, and certain other products without tobacco and/or nicotine; (ii) distribute a wide assortment of vaping related products to non-traditional retail via VaporBeast, Vapor Shark, Vapor Supply, and IVG; and (iii) distribute a wide assortment of vaping related products to individual consumers via Vapor Shark, Vapor World, and VaporFi branded retail outlets in addition to online platforms. Refer to the ‘Recent Developments’ section below for details regarding the Vapor Supply and IVG acquisitions. Our portfolio of brands includes some of the most widely recognized names in the OTP industry such as Stoker’s® in the Smokeless segment, Zig-Zag® in the Smoking segment, and VaporBeast® in the NewGen segment.
Operations
Our core tobacco business (Smokeless and Smoking segments) primarily generates revenues from the sale of our products to wholesale distributors who, in turn, resell the products to retail operations. Our acquisition of VaporBeast in the fourth quarter of 2016 expanded our revenue streams as we began selling directly to non-traditional retail outlets and to ultimate consumers via non-traditional retail outlets as well. Our acquisitions of Vapor Shark in the second quarter of 2017, Vapor Supply in the second quarter of 2018, and IVG in the third quarter of 2018 have further expanded our selling network by allowing us to directly reach ultimate consumers through Vapor Shark, Vapor World, and VaporFi branded retail outlets. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.
We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. Approximately 85% of our production, as measured by net sales, is outsourced to suppliers. The remaining 15% represents our moist snuff tobacco operations located in Dresden, TN, and Louisville, KY; the packaging of our pipe tobacco in Louisville, KY; and the proprietary e-liquids operations located in Oklahoma City, OK, Louisville, KY, and Miami, FL. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel. Our other principal expenses include interest expense among other expenses.
Key Factors Affecting Our Results of Operations
We consider the following to be the key factors affecting our results of operations:
| · | Our ability to further penetrate markets with our existing products; |
| · | Our ability to introduce new products and product lines that complement our core business; |
| · | Decreasing interest in some tobacco products among consumers; |
| · | Price sensitivity in our end-markets; |
| · | Marketing and promotional initiatives, which cause variability in our results; |
| · | General economic conditions, including consumer access to disposable income; |
| · | Cost and increasing regulation of promotional and advertising activities; |
| · | Cost of complying with regulation, including newly passed “deeming regulations”; |
| · | Counterfeit and other illegal products in our end-markets; |
| · | Our ability to identify attractive acquisition opportunities in OTP; and |
| · | Our ability to integrate acquisitions. |
Recent Developments
VMR
On October 2, 2018, VMR Products LLC (“VMR”), the supplier of V2 e-cigarettes to TPB under a long-term exclusive agreement for retail brick and mortar distribution and sales, was purchased by Juul Labs for a reported $75 million. Our contract anticipated such an event and affords an acquirer of VMR the right to terminate the contract, subject to certain terms and conditions including product buyback requirements and a termination payment based on the purchase price. On November 6, 2018, we received a letter from VMR, now owned by Juul Labs, stating that it would no longer accept orders and that we are permitted to continue to sell-through any V2 inventory. Our net sales of V2 products were $5.5 million for the nine months ended September 30, 2018. We have sufficient inventory on hand to satisfy sales through the first quarter of 2019. Thereafter, we intend to replace these volumes with new initiatives.
IVG
In September 2018, we acquired IVG for total consideration of $23.7 million satisfied through $14.4 million paid in cash, 153,079 shares of common stock with a fair value of $5.3 million, and a $4.0 million note payable to IVG’s former owners (“IVG Note”) which matures 18 months from the acquisition date. All principal and accrued and unpaid interest under the IVG Note is subject to indemnification obligations of the sellers pursuant to the International Vapor Group Stock Purchase Agreement dated as of September 5, 2018. The arrangement includes an additional $4.5 million of earnouts with both performance-based and service-based conditions payable to former IVG owners who became employees of the Company as a result of the acquisition. The portion of earnout payments a recipient will receive will be calculated by reference to certain performance metrics not to exceed a two-year period as specified within the acquisition agreement. The Company recorded earnout expense of approximately $0.4 million within the consolidated statement of income for the three months ended September 30, 2018, based on the probability of achieving the performance conditions.
IVG markets and sells a broad array of proprietary and third-party vapor products directly to adult consumers through an online platform under brand names such as VaporFi, South Beach Smoke, and Direct Vapor. IVG operates company-owned stores under the VaporFi brand and also operates as a franchisor to franchisee-owned stores. The acquisition of IVG adds a significant business-to-consumer distribution platform to the Company’s NewGen portfolio. Refer to Note 3 of Notes to Consolidated Financial Statements for more details regarding the IVG acquisition.
Vapor Supply
On April 30, 2018, we purchased the assets of Vapor Supply LLC, vaporsupply.com, and some of its affiliates including the Ecig.com domain through our subsidiary Vapor Acquisitions Company, LLC, for total consideration of $4.8 million paid in cash to strengthen its presence within the NewGen segment. Vapor Supply is a business-to-business e-commerce distribution platform servicing independent retail vape shops. Additionally, Vapor Supply manufactures and markets proprietary e-liquids under the DripCo brand and operates company-owned stores. Refer to Note 3 of Notes to Consolidated Financial Statements for more details regarding the Vapor Supply acquisition.
Credit Facility Refinancing
On March 7, 2018, we entered into a $250 million credit facility consisting of a $160 million 2018 First Lien Term Loan with Fifth Third Bank, as administrative agent, and other lenders, and a $50 million 2018 Revolving Credit Facility (collectively, the “2018 First Lien Credit Facility”) in addition to a $40 million 2018 Second Lien Term Loan (together with the 2018 First Lien Credit Facility, the “2018 Credit Facility”) with Prospect Capital Corporation, as administrative agent, and other lenders. The 2018 Credit Facility retained the $40 million accordion feature of the 2017 Credit Facility. Proceeds from the 2018 Credit Facility were used to repay, in full, the 2017 Credit Facility. We incurred a loss on extinguishment of debt of $2.4 million in the first quarter of 2018 as a result of the refinancing. Refer to the Long-Term Debt section for a more complete description of our credit facilities.
Critical Accounting Policies and Uses of Estimates
There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2017 Annual Report on Form 10-K with the exception of the items listed below.
Revenue Recognition
We adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP, on January 1, 2018. We recognize revenues, net of sales incentives and sales returns, including shipping and handling charges billed to customers, upon delivery of goods to the customer at an amount that we expect to be entitled to in exchange for those goods in accordance with the five-step analysis outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied.
A further requirement of ASU 2014-09 is for entities to disaggregate revenue recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Our management views business performance through segments that closely resemble the performance of major product lines. Thus, the primary, and most useful, disaggregation of our contract revenue for decision making purposes is the disaggregation by segment which can be found in Note 16 of Notes to Consolidated Financial Statements. An additional disaggregation of contract revenue by sales channel can be found within Note 16 as well.
Interest Rate Swaps
We enter into interest rate swap contracts to manage interest rate risk and reduce the volatility of future cash flows. We account for interest rate swap contracts under the provisions of ASC 815, Derivatives and Hedging. Swap contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these swap contracts are transferred from other comprehensive income into net income upon settlement of the derivative position or at maturity of the interest rate swap contract. Changes in fair value of any contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.
Recent Accounting Pronouncements
Refer to Note 2 of Notes to Consolidated Financial Statements included in this Quarterly Report for a description of recently issued accounting pronouncements, including those recently adopted.
Results of Operations
Comparison of the Three Months Ended September 30, 2018, to the Three Months Ended September 30, 2017
The table and discussion set forth below displays our consolidated results of operations (in thousands):
| | Three Months Ended September 30, | |
| | 2018 | | | 2017 | | | % Change | |
Consolidated Results of Operations Data: | | | | | | | | | |
Net sales | | | | | | | | | |
Smokeless products | | $ | 21,743 | | | $ | 21,294 | | | | 2.1 | % |
Smoking products | | | 28,079 | | | | 26,860 | | | | 4.5 | % |
NewGen products | | | 33,527 | | | | 25,186 | | | | 33.1 | % |
Total net sales | | | 83,349 | | | | 73,340 | | | | 13.6 | % |
Cost of sales | | | 47,138 | | | | 40,372 | | | | 16.8 | % |
Gross profit | | | | | | | | | | | | |
Smokeless products | | | 11,020 | | | | 11,516 | | | | -4.3 | % |
Smoking products | | | 14,814 | | | | 14,201 | | | | 4.3 | % |
NewGen products | | | 10,377 | | | | 7,251 | | | | 43.1 | % |
Total gross profit | | | 36,211 | | | | 32,968 | | | | 9.8 | % |
| | | | | | | | | | | | |
Selling, general, and administrative expenses | | | 23,253 | | | | 18,534 | | | | 25.5 | % |
Operating income | | | 12,958 | | | | 14,434 | | | | -10.2 | % |
Interest expense | | | 3,836 | | | | 4,027 | | | | -4.7 | % |
Interest income | | | (134 | ) | | | (4 | ) | | NM | |
Investment income | | | (89 | ) | | | (131 | ) | | | -32.1 | % |
Net periodic benefit (income) expense, excluding service cost | | | (45 | ) | | | 58 | | | NM | |
Income before income taxes | | | 9,390 | | | | 10,484 | | | | -10.4 | % |
Income tax expense | | | 1,436 | | | | 3,110 | | | | -53.8 | % |
Consolidated net income | | $
| 7,954 | | | $
| 7,374 | | | | 7.9 | % |
Net Sales: For the three months ended September 30, 2018, consolidated net sales increased to $83.3 million from $73.3 million for the three months ended September 30, 2017, an increase of $10.0 million or 13.6%. The increase in net sales was primarily driven by volume growth in Smoking and NewGen which includes the addition of one month of IVG sales in 2018.
For the three months ended September 30, 2018, net sales in the Smokeless products segment increased to $21.7 million from $21.3 million for the three months ended September 30, 2017, an increase of $0.4 million or 2.1%. For the three months ended September 30, 2018, volume decreased 2.2% and price/mix increased 4.3%. The increase in net sales was primarily driven by the continuing growth of Stoker’s® MST partially offset by declines in chewing tobacco attributable to increased competition, our promotional timing, and a continuing segment shift to lower price products.
For the three months ended September 30, 2018, net sales in the Smoking products segment increased to $28.1 million from $26.9 million for the three months ended September 30, 2017, an increase of $1.2 million or 4.5%. For the three months ended September 30, 2018, volume increased 3.0% and price/mix increased 1.5%. Net sales growth was primarily driven by volume growth for our Zig-Zag® branded papers and cigar wraps equating to $2.0 million of increases offset by $0.7 million of decreases related to our strategic decision to de-emphasize the low margin cigar products business and line rationalization of our MYO tobacco line.
For the three months ended September 30, 2018, net sales in the NewGen products segment increased to $33.5 million from $25.2 million for the three months ended September 30, 2017, an increase of $8.3 million or 33.1%. The increase in net sales was primarily driven by continued VaporBeast momentum, Vapor Supply net sales, and one month of IVG net sales.
Gross Profit: For the three months ended September 30, 2018, consolidated gross profit increased to $36.2 million from $33.0 million for the three months ended September 30, 2017, an increase of $3.2 million or 9.8%. Gross profit as a percentage of revenue decreased to 43.4% for the three months ended September 30, 2018, from 45.0% for the three months ended September 30, 2017, primarily due to the NewGen segment, which has lower margins, becoming a larger share of the Company.
For the three months ended September 30, 2018, gross profit in the Smokeless products segment decreased to $11.0 million from $11.5 million for the three months ended September 30, 2017, a decrease of $0.5 million or 4.3%. Gross profit as a percentage of net sales decreased to 50.7% of net sales for the three months ended September 30, 2018, from 54.1% of net sales for the three months ended September 30, 2017. The decrease in gross profit as a percentage of revenue was primarily driven by an unfavorable LIFO impact when compared to the prior year.
For the three months ended September 30, 2018, gross profit in the Smoking products segment increased to $14.8 million from $14.2 million for the three months ended September 30, 2017, an increase of $0.6 million or 4.3%. Gross profit as a percentage of net sales decreased to 52.8% of net sales for the three months ended September 30, 2018, from 52.9% of net sales for the three months ended September 30, 2017, primarily due to an unfavorable LIFO impact when compared to the prior year.
For the three months ended September 30, 2018, gross profit in the NewGen products segment increased to $10.4 million from $7.3 million for the three months ended September 30, 2017, an increase of $3.1 million or 43.1%. Gross profit as a percentage of net sales increased to 31.0% of net sales for the three months ended September 30, 2018, from 28.8% of net sales for the three months ended September 30, 2017, primarily as a result of the addition of IVG, a business-to-consumer operation which generally has higher margins, in 2018.
Selling, General, and Administrative Expenses: For the three months ended September 30, 2018, selling, general, and administrative expenses increased to $23.3 million from $18.5 million for the three months ended September 30, 2017, an increase of $4.7 million or 25.5% due primarily to the inclusion of Vapor Supply and IVG selling, general, and administrative expenses, transaction costs associated with the IVG acquisition and variable costs associated with increased sales at VaporBeast partially offset by the prepayment penalty associated with the loan made to a supplier during the second quarter of 2018.
Interest Expense: For the three months ended September 30, 2018, interest expense decreased to $3.8 million from $4.0 million for the three months ended September 30, 2017, as a result of lower interest rates from our March 2018 refinancing of our credit facility.
Interest Income: For the three months ended September 30, 2018, interest income increased to $0.1 million from less than $0.1 million for the three months ended September 30, 2017, as a result of interest received from a note receivable issued to a supplier during the second quarter of 2018.
Income Tax Expense: Our income tax expense of $1.4 million was 15.3% of income before income taxes for the three months ended September 30, 2018 compared to 29.7% for the three months ended September 30, 2017. The decrease is primarily a result of the change in the federal tax rate from 35% to 21% and the change in the Kentucky tax rate from 6% to 5%.
Investment Income: Investment income relating to investment of the MSA escrow deposits was approximately $0.1 million for the three months ended September 30, 2018 and 2017.
Consolidated Net Income: Due to the factors described above, consolidated net income for the three months ended September 30, 2018 and 2017, was $8.0 million and $7.4 million, respectively.
Comparison of the Nine Months Ended September 30, 2018, to the Nine Months Ended September 30, 2017
The table and discussion set forth below displays our consolidated results of operations (in thousands):
| | Nine Months Ended September 30, | |
| | 2018 | | | 2017 | | | % Change | |
Consolidated Results of Operations Data: | | | | | | | | | |
Net sales | | | | | | | | | |
Smokeless products | | $ | 66,900 | | | $ | 63,563 | | | | 5.2 | % |
Smoking products | | | 84,403 | | | | 81,056 | | | | 4.1 | % |
NewGen products | | | 87,089 | | | | 67,595 | | | | 28.8 | % |
Total net sales | | | 238,392 | | | | 212,214 | | | | 12.3 | % |
Cost of sales | | | 134,577 | | | | 119,508 | | | | 12.6 | % |
Gross profit | | | | | | | | | | | | |
Smokeless products | | | 34,546 | | | | 32,385 | | | | 6.7 | % |
Smoking products | | | 43,158 | | | | 42,018 | | | | 2.7 | % |
NewGen products | | | 26,111 | | | | 18,303 | | | | 42.7 | % |
Total gross profit | | | 103,815 | | | | 92,706 | | | | 12.0 | % |
| | | | | | | | | | | | |
Selling, general, and administrative expenses | | | 66,314 | | | | 53,764 | | | | 23.3 | % |
Operating income | | | 37,501 | | | | 38,942 | | | | -3.7 | % |
Interest expense | | | 11,073 | | | | 13,010 | | | | -14.9 | % |
Interest income | | | (262 | ) | | | (8 | ) | | NM | |
Investment income | | | (328 | ) | | | (334 | ) | | | -1.8 | % |
Loss on extinguishment of debt | | | 2,384 | | | | 6,116 | | | | -61.0 | % |
Net periodic benefit expense, excluding service cost | | | 176 | | | | 174 | | | | 1.1 | % |
Income before income taxes | | | 24,458 | | | | 19,984 | | | | 22.4 | % |
Income tax expense | | | 4,153 | | | | 3,850 | | | | 7.9 | % |
Consolidated net income | | | 20,305 | | | | 16,134 | | | | 25.9 | % |
Net loss attributable to non-controlling interest | | | - | | | | (556 | ) | | NM | |
Net income attributable to Turning Point Brands, Inc. | | $ | 20,305 | | | $ | 16,690 | | | | 21.7 | % |
Net Sales: For the nine months ended September 30, 2018, consolidated net sales increased to $238.4 million from $212.2 million for the nine months ended September 30, 2017, an increase of $26.2 million or 12.3%. The increase in net sales was primarily driven by volume growth in the NewGen segment which includes an additional quarter of Vapor Shark results in 2018 and the acquisitions of Vapor Supply and IVG.
For the nine months ended September 30, 2018, net sales in the Smokeless products segment increased to $66.9 million from $63.6 million for the nine months ended September 30, 2017, an increase of $3.3 million or 5.2% primarily due to the continuing growth of Stoker’s® MST.
For the nine months ended September 30, 2018, net sales in the Smoking products segment increased to $84.4 million from $81.1 million for the nine months ended September 30, 2017, an increase of $3.3 million or 4.1% primarily driven by the continued growth of our Zig-Zag® branded papers and cigar wraps offset by decreases related to our strategic decision to de-emphasize the low margin cigar products business and line rationalization of our MYO tobacco line.
For the nine months ended September 30, 2018, net sales in the NewGen products segment increased to $87.1 million from $67.6 million for the nine months ended September 30, 2017, an increase of $19.5 million or 28.8%. The increase in net sales was primarily driven by continued VaporBeast momentum, one additional quarter of Vapor Shark results in 2018, and the acquisitions of Vapor Supply and IVG.
Gross Profit: For the nine months ended September 30, 2018, consolidated gross profit increased to $103.8 million from $92.7 million for the nine months ended September 30, 2017, an increase of $11.1 million or 12.0%. Gross profit as a percentage of revenue decreased to 43.5% for the nine months ended September 30, 2018, from 43.7% for the nine months ended September 30, 2017, primarily due to the NewGen segment, which has lower margins, becoming a larger share of the Company.
For the nine months ended September 30, 2018, gross profit in the Smokeless products segment increased to $34.5 million from $32.4 million for the nine months ended September 30, 2017, an increase of $2.2 million or 6.7%. Gross profit as a percentage of net sales increased to 51.6% of net sales for the nine months ended September 30, 2018, from 50.9% of net sales for the nine months ended September 30, 2017. The increase in gross profit as a percentage of revenue is primarily due to a favorable LIFO impact when compared to the prior year.
For the nine months ended September 30, 2018, gross profit in the Smoking products segment increased to $43.2 million from $42.0 million for the nine months ended September 30, 2017, an increase of $1.1 million or 2.7%. Gross profit as a percentage of net sales decreased to 51.1% of net sales for the nine months ended September 30, 2018, from 51.8% of net sales for the nine months ended September 30, 2017, primarily due to new product launch costs associated with our Zig-Zag® branded papers and cigar wraps product lines.
For the nine months ended September 30, 2018, gross profit in the NewGen products segment increased to $26.1 million from $18.3 million for the nine months ended September 30, 2017, an increase of $7.8 million or 42.7%. Gross profit as a percentage of net sales increased to 30.0% of net sales for the nine months ended September 30, 2018, from 27.1% of net sales for the nine months ended September 30, 2017, primarily due to acquisition activity which has resulted in business-to-consumer sales, which generally have higher margins, becoming a larger share of the NewGen segment.
Selling, General, and Administrative Expenses: For the nine months ended September 30, 2018, selling, general, and administrative expenses increased to $66.3 million from $53.8 million for the nine months ended September 30, 2017, an increase of $12.6 million or 23.3%, due primarily to the inclusion of Vapor Supply and IVG selling, general, and administrative expenses in 2018 along with an additional quarter of Vapor Shark when compared to 2017, transaction costs associated with the Vapor Supply and IVG acquisitions, higher legal and litigation expenses associated with our anti-counterfeiting initiative, and variable costs associated with increased sales at VaporBeast partially offset by a receivable reserve reversal and prepayment penalty, both of which are associated with the loan issued to a supplier in the second quarter of 2018 which was repaid during the third quarter of 2018.
Interest Expense: For the nine months ended September 30, 2018, interest expense decreased to $11.1 million from $13.0 million for the nine months ended September 30, 2017, as a result of lower interest rates from our March 2018 refinancing of our credit facility.
Interest Income: For the nine months ended September 30, 2018, interest income increased to $0.3 million from less than $0.1 million for the nine months ended September 30, 2017, as a result of interest and fees received from a note receivable issued to a supplier during the second quarter of 2018.
Income Tax Expense: Our income tax expense of $4.2 million was 17.0% of income before income taxes for the nine months ended September 30, 2018, compared to 19.3% for the nine months ended September 30, 2017. The decrease is a result of the change in the federal tax rate from 35% to 21%, the change in the Kentucky tax rate from 6% to 5%, and lower stock option exercises in 2018 compared to 2017.
Investment Income: Investment income relating to investment of the MSA escrow deposits was approximately $0.3 million for the nine months ended September 30, 2018 and 2017.
Loss on Extinguishment of Debt: For the nine months ended September 30, 2018, loss on extinguishment of debt was $2.4 million as the result of refinancing our credit facility in the first quarter of 2018. For the nine months ended September 30, 2017, loss on extinguishment of debt was $6.1 million as the result of refinancing our credit facility in the first quarter of 2017.
Consolidated Net Income: Due to the factors described above, consolidated net income for the nine months ended September 30, 2018 and 2017, was $20.3 million and $16.1 million, respectively.
Net Loss Attributable to Non-Controlling Interest: Net loss attributable to non-controlling interest of $0.6 million for the nine months ended September 30, 2017, is related to Vapor Shark being a VIE in the second quarter of 2017.
Net Income Attributable to Turning Point Brands, Inc.: Due to the factors described above, net income attributable to Turning Point Brands, Inc., for the nine months ended September 30, 2018 and 2017, was $20.3 million and $16.7 million, respectively.
EBITDA and Adjusted EBITDA
To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our credit agreements contain financial covenants which use Adjusted EBITDA calculations.
We define “EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider ordinary course in our evaluation of ongoing operating performance.
Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.
(in thousands) | | Three Months Ended September 30, | |
| | 2018 | | | 2017 | |
Consolidated net income | | $ | 7,954 | | | $ | 7,374 | |
Add: | | | | | | | | |
Interest expense | | | 3,836 | | | | 4,027 | |
Interest income | | | (134 | ) | | | (4 | ) |
Income tax expense | | | 1,436 | | | | 3,110 | |
Depreciation expense | | | 479 | | | | 421 | |
Amortization expense | | | 206 | | | | 175 | |
EBITDA | | $ | 13,777 | | | $ | 15,103 | |
Components of Adjusted EBITDA | | | | | | | | |
LIFO adjustment (a) | | | 201 | | | | (641 | ) |
Pension/postretirement expense (b) | | | (18 | ) | | | 84 | |
Stock options, restricted stock, and incentives expense (c) | | | 367 | | | | 226 | |
Foreign exchange hedging (d) | | | 70 | | | | - | |
Strategic initiatives (e) | | | 1,126 | | | | 219 | |
New product launch costs (f) | | | 545 | | | | 566 | |
Product line rationalizations (g) | | | 301 | | | | 314 | |
Organizational development (h) | | | 98 | | | | - | |
Adjusted EBITDA | | $ | 16,467 | | | $ | 15,871 | |
| (a) | Represents expense related to an inventory valuation allowance for last-in, first-out (“LIFO”) reporting. |
| (b) | Represents our non-cash Pension/postretirement expense. |
| (c) | Represents non-cash stock options, restricted stock and incentives expense. |
| (d) | Represents non-cash gain and loss stemming from our foreign exchange hedging activities. |
| (e) | Represents the fees incurred for the study of strategic initiatives and acquisition expenses. |
| (f) | Represents product launch costs of our new product lines. |
| (g) | Represents costs associated with discontinued products related to product line rationalization. |
| (h) | Represents costs associated with departmental restructuring. |
(in thousands) | | Nine Months Ended September 30, | |
| | 2018 | | | 2017 | |
Net income attributable to Turning Point Brands, Inc. | | $ | 20,305 | | | $ | 16,690 | |
Add: | | | | | | | | |
Interest expense | | | 11,073 | | | | 13,010 | |
Interest income | | | (262 | ) | | | (8 | ) |
Loss on extinguishment of debt | | | 2,384 | | | | 6,116 | |
Income tax expense | | | 4,153 | | | | 3,850 | |
Depreciation expense | | | 1,596 | | | | 1,192 | |
Amortization expense | | | 557 | | | | 526 | |
EBITDA | | $ | 39,806 | | | $ | 41,376 | |
Components of Adjusted EBITDA | | | | | | | | |
LIFO adjustment (a) | | | 144 | | | | 246 | |
Pension/postretirement expense (b) | | | 254 | | | | 252 | |
Stock options, restricted stock, and incentives expense (c) | | | 1,056 | | | | 446 | |
Foreign exchange hedging (d) | | | 70 | | | | (90 | ) |
Product line rationalizations (e) | | | 1,309 | | | | 314 | |
Strategic initiatives (f) | | | 2,755 | | | | 990 | |
New product launch costs (g) | | | 1,227 | | | | 1,727 | |
Organizational development (h) | | | 778 | | | | - | |
Adjusted EBITDA | | $ | 47,399 | | | $ | 45,261 | |
| (a) | Represents expense related to an inventory valuation allowance for last-in, first-out (“LIFO”) reporting. |
| (b) | Represents our non-cash Pension/postretirement expense. |
| (c) | Represents non-cash stock options, restricted stock and incentives expense. |
| (d) | Represents non-cash gain and loss stemming from our foreign exchange hedging activities. |
| (e) | Represents costs associated with discontinued products related to product line rationalization. |
| (f) | Represents the fees incurred for the study of strategic initiatives and acquisition expenses. |
| (g) | Represents product launch costs of our new product lines. |
| (h) | Represents costs associated with departmental restructuring. |
Liquidity and Capital Reserves
Our principal uses for cash are working capital, debt service, and capital expenditures. We believe our cash flows from operations and borrowing availability under our 2018 Revolving Credit Facility (as defined herein) are adequate to satisfy our operating cash requirements for the foreseeable future.
Our working capital, which we define as current assets less current liabilities, increased $6.8 million to $48.1 million at September 30, 2018, compared with $41.3 million at December 31, 2017. The increase in working capital is primarily due to inventory increases resulting from the Vapor Supply asset purchase and the IVG acquisition, in addition to pre-tariff inventory buys within our existing operations, partially offset by borrowings against the 2018 Revolving Credit Facility to support acquisitions.
| | As of | |
(in thousands) | | September 30, 2018 | | | December 31, 2017 | |
| | | | | | |
Current assets | | $ | 112,223 | | | $ | 79,493 | |
Current liabilities | | | 64,161 | | | | 38,230 | |
Working capital | | $ | 48,062 | | | $ | 41,263 | |
Cash Flows from Operating Activities
For the nine months ended September 30, 2018, net cash provided by operating activities was $1.0 million compared to net cash provided by operating activities of $20.4 million for the nine months ended September 30, 2017, a decrease of $19.4 million, primarily due to inventory increases to support increased sales and pre-tariff inventory buys.
Cash Flows from Investing Activities
For the nine months ended September 30, 2018, net cash used by investing activities was $21.9 million compared to net cash used in investing activities of $0.5 million for the nine months ended September 30, 2017, a decrease of $21.5 million, primarily due to the Vapor Supply and IVG acquisitions.
Cash Flows from Financing Activities
For the nine months ended September 30, 2018, net cash provided by financing activities was $16.7 million compared to net cash used in financing activities of $18.2 million for the nine months ended September 30, 2017, an increase of $34.9 million, primarily due to borrowings against our 2018 Revolving Credit Facility to fund our investing activities.
Dividends
On November 9, 2017, our Board of Directors approved the initiation of a cash dividend to shareholders. The initial quarterly dividend of $0.04 per common share was paid on December 15, 2017, to shareholders of record at the close of business on November 27, 2017. The most recent dividend of $0.04 per common share was paid on October 12, 2018, to shareholders of record at the close of business on September 24, 2018.
Long-Term Debt
As of September 30, 2018, we were in compliance with the financial and restrictive covenants of the 2018 Credit Facility. The following table provides outstanding balances of our debt instruments.
(in thousands) | | September 30, 2018 | | | December 31, 2017 | |
2018 Revolving Credit Facility | | $ | 30,000 | | | $ | - | |
2018 First Lien Term Loan | | | 156,000 | | | | - | |
2018 Second Lien Term Loan | | | 40,000 | | | | - | |
Note payable - IVG | | | 4,000 | | | | - | |
2017 Revolving Credit Facility | | | - | | | | 8,000 | |
2017 First Lien First Out Term Loan | | | - | | | | 105,875 | |
2017 First Lien Second Out Term Loan | | | - | | | | 34,738 | |
2017 Second Lien Term Loan | | | - | | | | 55,000 | |
Note payable - VaporBeast | | | - | | | | 2,000 | |
| | | 230,000 | | | | 205,613 | |
Less deferred financing charges | | | (3,471 | ) | | | (3,573 | ) |
Less revolving credit facility | | | (30,000 | ) | | | (8,000 | ) |
Less current maturities of long-term debt | | | (8,000 | ) | | | (7,850 | ) |
Notes payable and long-term debt | | $ | 188,529 | | | $ | 186,190 | |
2018 Credit Facility
The 2018 Credit Facility contains customary events of default including payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to certain other material indebtedness in excess of specified amounts, certain events of bankruptcy and insolvency, certain ERISA events, judgments in excess of specified amounts, and change in control defaults. The 2018 Credit Facility also contains certain negative covenants customary for facilities of these types including covenants that, subject to exceptions described in the 2018 Credit Facility, restrict our ability: (i) to pledge assets, (ii) to incur additional indebtedness, (iii) to pay dividends, (iv) to make distributions, (v) to sell assets, and (vi) to make investments. Refer to Note 17 of Notes to Consolidated Financial Statements for further information regarding dividend restrictions.
2018 First Lien Credit Facility: The 2018 First Lien Term Loan and the 2018 Revolving Credit Facility bear interest at LIBOR plus a spread of 2.75% to 3.50% based on our senior leverage ratio. The 2018 First Lien Term Loan has quarterly required payments of $2.0 million beginning June 30, 2018, increasing to $3.0 million on June 30, 2020, and increasing to $4.0 million on June 30, 2022. The 2018 First Lien Credit Facility has a maturity date of March 7, 2023. The 2018 First Lien Term Loan is secured by a first priority lien on substantially all of the assets of the borrowers and the guarantors thereunder, including a pledge of our capital stock, other than certain excluded assets (the “Collateral”). The 2018 First Lien Credit Facility contains certain financial covenants including maximum senior leverage ratio of 3.50x with step-downs to 3.00x, a maximum total leverage ratio of 4.50x with step-downs to 4.00x, and a minimum fixed charge coverage ratio of 1.20x. The weighted average interest rate of the 2018 First Lien Term Loan was 5.34% at September 30, 2018. The weighted average interest rate of the 2018 Revolving Credit Facility was 6.05% at September 30, 2018. At September 30, 2018, we had $30.0 million of borrowings outstanding under the 2018 Revolving Credit Facility. The $20.0 million unused portion of the 2018 Revolving Credit Facility is reduced by a $0.5 million letter of credit with Fifth Third Bank, resulting in $19.5 million of availability under the 2018 Revolving Credit Facility at September 30, 2018.
2018 Second Lien Credit Facility: The 2018 Second Lien Credit Facility bears interest at a rate of LIBOR plus 7.00% and has a maturity date of March 7, 2024. The 2018 Second Lien Term Loan is secured by a second priority interest in the Collateral and is guaranteed by the same entities as the 2018 First Lien Term Loan. The 2018 Second Lien Credit Facility contains certain financial covenants including a maximum senior leverage ratio of 3.75x with step-downs to 3.50x, a maximum total leverage ratio of 4.75x with step-downs to 4.50x, and a minimum fixed charge coverage ratio of 1.10x. The weighted average interest rate of the 2018 Second Lien Term Loan was 9.05% at September 30, 2018.
Note Payable – IVG
In September 2018, we issued a note payable to IVG’s former shareholders (“IVG Note”). The IVG Note is $4.0 million principal with 6.0% interest compounding annually and matures on March 1, 2020.
Note Payable – VaporBeast
On November 30, 2016, we issued a note payable to VaporBeast’s former shareholders (“VaporBeast Note”). The VaporBeast Note was $2.0 million principal with 6% interest compounded monthly and matured on May 30, 2018, at which time it was paid in full.
Off-balance Sheet Arrangements
During the third quarter of 2018 we executed forward contracts for the purchase of €2.3 million. During 2017, we executed no forward contracts. At September 30, 2018, and December 31, 2017, we had forward contracts for the purchase of €5.5 million and €0 million, respectively.
Contractual Obligations
As of September 30, 2018, there had been no material changes outside the ordinary course of business to our contractual obligations as of December 31, 2017, as reported in our 2017 Annual Report on Form 10-K, with the exception of changes to our long-term debt obligations due to the refinancing discussed in the ‘Long-Term Debt’ section.
The following tables summarize our contractual obligations (in thousands):
| | Payments due by period as of September 30, 2018 | |
| | Total | | | Less than 1 year | | | 1-3 years | | | 4-5 years | | | More than 5 years | |
Long-term debt obligations, including interest | | $ | 280,795 | | | $ | 51,969 | | | $ | 44,632 | | | $ | 142,600 | | | $ | 41,594 | |
| | Payments due by period as of December 31, 2017 | |
| | Total | | | Less than 1 year | | | 1-3 years | | | 4-5 years | | | More than 5 years | |
Long-term debt obligations, including interest | | $ | 266,052 | | | $ | 29,803 | | | $ | 42,444 | | | $ | 193,805 | | | $ | - | |
Inflation
We believe that any effect of inflation at current levels will be minimal. Historically, we have been able to increase prices at a rate equal to or greater than that of inflation and believe that we will continue to be able to do so for the foreseeable future. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our successful procurement with regard to our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Foreign Currency Sensitivity
Although we engaged in hedging inventory purchases during the three months ended September 30, 2018, there have been no material changes in our exposure to exchange rate fluctuation risk, as reported within our 2017 Annual Report on Form 10-K, during the period. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2017 Annual Report on Form 10-K filed with the SEC.
Credit Risk
There have been no material changes in our exposure to credit risk, as reported within our 2017 Annual Report on Form 10-K, during the three months ended September 30, 2018. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2017 Annual Report on Form 10-K filed with the SEC.
Interest Rate Sensitivity
Our March 2018 refinancing resulted in all of our long-term debt instruments having variable interest rates that fluctuate with market rates. To reduce the volatility of future cash flows, we entered into interest rate swap agreements with lenders under the 2018 Credit Facility in March 2018. At September 30, 2018, $70 million of our outstanding long-term debt carrying variable rates is covered by the interest rate swap agreements and, thus, effectively bears interest at a fixed rate. We believe the effect, if any, of reasonably possible near-term changes in interest rates on our consolidated financial position, results of operations, or cash flows would not be significant. A 1% increase in the interest rate would change pre-tax income by approximately $1.5 million per year. Refer to Note 4 of Notes to Consolidated Financial Statements located at Part I, Item 1, for additional information regarding the interest rate swaps.
Item 4. Controls and Procedures
We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended (the “Act”)) as of September 30, 2018. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by us in the reports we file or submit under the Act is: (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosures.
There have been no changes in the Company’s internal control over financial reporting during the most recent fiscal quarter which have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
We are a party from time to time to various proceedings in the ordinary course of business. For a description of the Master Settlement Agreement, to which we are a party, see “Financial Statements and Supplementary Data - Note 2 Summary of Significant Accounting Policies: Risk and Uncertainties.” Other than the proceedings mentioned below, there is no material litigation, arbitration or governmental proceeding currently pending against us or any of our officers or directors in their capacity as such, and we and our officers and directors have not been subject to any such proceeding.
Other major tobacco companies are defendants in product liability claims. In a number of these cases, the amounts of punitive and compensatory damages sought are significant and could have a material adverse effect on our business and results of operations. The Company is a defendant in certain cases which have been dormant for many years, which cases have now been dismissed with prejudice.
We are subject to several lawsuits alleging personal injuries resulting from malfunctioning vaporizer devices and may be subject to claims in the future relating to our other NewGen products. We are still evaluating these claims and the potential defenses to them. For example, we did not design or manufacture the products at issue; rather, we were merely the distributor. Nonetheless, there can be no assurance that we will prevail in these cases, and they could have a material adverse effect on our business and results of operations. Because of their relative novelty, electronic cigarette and vaporizer product manufacturers and sellers have only recently become subject to litigation.
See ‘Risk Factors—We may become subject to significant product liability litigation’ within our 2017 Annual Report on Form 10-K for additional details.
In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our 2017 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2017 Annual Report on Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
During the period of this report, the Company issued 153,079 unregistered shares of the Company’s common stock to the former stockholders of IVG as partial consideration for the Company’s acquisition of IVG. In September 2018, the Company acquired IVG for total consideration of $23.7 million satisfied through $14.4 million paid in cash, 153,079 shares of common stock with a fair value of $5.3 million, and a $4.0 million note payable to IVG’s former owners. Refer to Note 3 of Notes to Consolidated Financial Statements located at Part I, Item 1, for additional information.
The issuance of unregistered shares was made by the Company in reliance upon Section 4(a)(2) of the Securities Act of 1933, a amended (the “1933 Act”) and Regulation D promulgated thereunder. All of the individuals and/or entities that received the unregistered securities were “accredited investors” and were all known to the Company and its management through pre-existing business relationships. All purchasers were provided access to all material information, which they requested, and all information necessary to verify such information and were afforded access to management of the Company in connection with their purchases. All purchasers of the unregistered securities acquired such securities for investment and not with a view toward distribution, acknowledging such intent to the Company. All certificates representing such securities that were issued contained restrictive legends, prohibiting further transfer of the securities, without such securities either being first registered or otherwise exempt from registration in any further resale or disposition.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
Exhibit No. | Description |
| |
| International Vapor Group Stock Purchase Agreement dated as of September 5, 2018, between Turning Point Brands, Inc. and International Vapor Group, LLC.*+ |
| |
| Rule 13a-14(a)/15d-14(a) Certification of Lawrence S. Wexler.* |
| |
| Rule 13a-14(a)/15d-14(a) Certification of Robert Lavan.* |
| |
| Rule 13a-14(a)/15d-14(a) Certification of Brian Wigginton.* |
| |
| Section 1350 Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.* |
| |
101 | XBRL (eXtensible Business Reporting Language). The following materials from Turning Point Brands, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018, filed on November 7, 2018, formatted in XBRL: (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of comprehensive income, (iv) consolidated statements of cash flows, and (v) the notes to consolidated financial statements.* |
* | Filed or furnished herewith |
+ | Certain schedules, appendices and exhibits to this agreement have been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementally to the Securities and Exchange Commission staff upon request. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| TURNING POINT BRANDS, INC. |
| |
| | By: /s/ Lawrence S. Wexler |
| | Name: Lawrence S. Wexler |
| | Title: President and Chief Executive Officer |
| | |
| | By: /s/ Robert Lavan |
| | Name: Robert Lavan |
| | Title: Chief Financial Officer |
| | |
| | By: /s/ Brian Wigginton |
| | Name: Brian Wigginton |
| | Title: Chief Accounting Officer |
Date: November 7, 2018